Croft J B, Giles W H, Roegner R H, Anda R F, Casper M L, Livengood J R
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA.
J Fam Pract. 1997 Apr;44(4):382-90.
Despite the recent availability of new classes of heart failure medications, little is known about national patterns in the actual physician utilization of these drugs.
In the National Ambulatory Medical Care Survey, 2912 US physicians reported on 16,968 office visits in 1991-1992 with patients aged > or = 65 years. National estimates were obtained from weighted results that accounted for the complex sampling design.
An estimated 8.3 million (2.6%) office visits with older adults involved heart failure. This included 9.3% of visits to cardiologists, 4.3% to internists, 3.5% to general and family physicians, and 0.6% to other physicians. The most frequently prescribed medications during visits with these patients were diuretics (69%), digitalis compounds (46%), angiotensin-converting enzyme inhibitors (30%), and nitrates (19%). Internists and general and family physicians prescribed angiotensin-converting enzyme inhibitors, digitalis compounds, and loop diuretics for patients with heart failure less often than did cardiologists.
These are the first national surveillance estimates of physician practices in the management of heart failure. These data were collected during the same period in which heart failure clinical trial results were initially published, and they provide a baseline for monitoring the influence of recent clinical practice guidelines and professional education on changes in the management of heart failure by primary care physicians.
尽管最近有了新的心力衰竭药物类别,但对于这些药物在全国范围内医生实际使用的模式却知之甚少。
在全国门诊医疗调查中,2912名美国医生报告了1991 - 1992年对年龄≥65岁患者的16968次门诊情况。全国估计数来自考虑了复杂抽样设计的加权结果。
估计有830万(2.6%)次对老年人的门诊涉及心力衰竭。这包括9.3%的心脏病专家门诊、4.3%的内科医生门诊、3.5%的普通和家庭医生门诊以及0.6%的其他医生门诊。在这些患者的门诊中最常开具的药物是利尿剂(69%)、洋地黄类化合物(46%)、血管紧张素转换酶抑制剂(30%)和硝酸盐类(19%)。内科医生以及普通和家庭医生为心力衰竭患者开具血管紧张素转换酶抑制剂、洋地黄类化合物和襻利尿剂的频率低于心脏病专家。
这些是对医生治疗心力衰竭实践的首次全国性监测估计。这些数据是在心力衰竭临床试验结果最初发表的同一时期收集的,它们为监测近期临床实践指南和专业教育对初级保健医生治疗心力衰竭变化的影响提供了一个基线。